← Eichor
Condition: Critical Limb Threatening Ischemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Critical Limb Threatening Ischemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Leg Ischaemia Management Collaboration
Phase N/A · 1 location(s) · University of Leicester · NCT04027244IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial
NA · 1 location(s) · Biotyx Medical (Shenzhen) Co., Ltd. · NCT05971394Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
Phase 3 · 2 location(s) · Mercator MedSystems, Inc. · NCT04433572miRNAs in Critical Limb Ischemia (miRNACLI)
Phase N/A · 1 location(s) · IRCCS Policlinico S. Donato · NCT06066268NOrmoBaric Oxygen Therapy Use In Critical Limb ISchemia
Phase N/A · 3 location(s) · University Hospital, Angers · NCT06238050Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Diseas
NA · 1 location(s) · R3 Vascular Inc. · NCT06075940Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease
NA · 1 location(s) · Maria Cecilia Hospital · NCT07588295CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common
Phase N/A · 2 location(s) · Yale University · NCT05145478Additional Hyperbaric Oxygen After Lower Extremity Amputation
NA · 2 location(s) · Oslo University Hospital · NCT03594344Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease
Phase 4 · 1 location(s) · Cell Biopeutics Resources Sdn Bhd · NCT05854641Nutrition in Patient With Critical Limb Ischemia
EARLY_Phase 1 · 1 location(s) · Boston Medical Center · NCT03529019FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
NA · 6 location(s) · Versono Medical Ltd · NCT06492733Acceleration Time Assessment for Prediction of Critical Limb Ischemia
Phase N/A · 3 location(s) · Centre Hospitalier le Mans · NCT06296576Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients
NA · 1 location(s) · Johns Hopkins University · NCT05830721FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial
NA · 1 location(s) · Paracelsus Medical University · NCT06082466Prospective Cohort of Patients With Critical Limb Ischemia Undergoing Revascularization
Phase N/A · 1 location(s) · Fondation Hôpital Saint-Joseph · NCT04312451FAZA PET/MRI in CLI Patients Pre and Post Revascularization
NA · 1 location(s) · University Health Network, Toronto · NCT04054609Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adv
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06318767PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NA · 30 location(s) · LimFlow, Inc. · NCT05313165Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
Phase N/A · 9 location(s) · EndoCore Lab s.r.l. · NCT06277362Serrantor OCT Study
NA · 2 location(s) · Cagent Vascular LLC · NCT06434194Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Phase 4 · 1 location(s) · Cell Biopeutics Resources Sdn Bhd · NCT05854615Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronym
EARLY_Phase 1 · 1 location(s) · Aplagon Oy · NCT06204237TP03HN106 in Patients With Critical Limb Ischemia
Phase 2 · 1 location(s) · Talengen Institute of Life Sciences, Shenzhen, P.R. China. · NCT06482892Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
Phase N/A · 3 location(s) · University Hospitals Cleveland Medical Center · NCT06544135Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Pat
NA · 1 location(s) · Stentit · NCT07006467Pressure (Fractional Flow Reserve) and Flow (Vascular Flow Reserve) Measurements During Peripheral Arterial Intervention
Phase N/A · 1 location(s) · Dr. Konstantinos Katsanos · NCT07052435
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.